A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

NCT03971422 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Myasthenia Gravis

Interventions

DRUG: Rozanolixizumab
OTHER: Placebo

Sponsor

UCB Biopharma SRL